Michigan Rx Rebate Program Decision Should Be Left To HHS, DoJ Tells Court
Executive Summary
HHS' approval of the Michigan Medicaid supplemental rebate program should be given deference in the Washington, D.C. federal court's review of the program, the Department of Justice said during oral arguments Aug. 28
You may also be interested in...
PhRMA v. HHS
D.C. federal court will hear additional arguments on the Pharmaceutical Research & Manufacturers of America's challenge of HHS' approval of the Michigan Medicaid supplemental rebate program Jan. 24. The court wants information on the effect the non-Medicaid aspects of the program will have on Medicaid beneficiaries. During oral arguments Jan. 6, the Department of Justice said the court should defer to HHS' approval (1"The Pink Sheet" Sept. 2, p. 6)...
PhRMA v. HHS
D.C. federal court will hear additional arguments on the Pharmaceutical Research & Manufacturers of America's challenge of HHS' approval of the Michigan Medicaid supplemental rebate program Jan. 24. The court wants information on the effect the non-Medicaid aspects of the program will have on Medicaid beneficiaries. During oral arguments Jan. 6, the Department of Justice said the court should defer to HHS' approval (1"The Pink Sheet" Sept. 2, p. 6)...
Michigan Rx Rebate Program Upheld In State Court; Federal Suit Pending
Michigan Medicaid's statutory authority to collect supplemental rebates has been upheld by the Michigan Court of Appeals